A Novel Neurotrophic Agent, T-817MA [1-{3-[2-(1-Benzothiophen-5-yl) Ethoxy] Propyl}-3-azetidinol Maleate], Attenuates Amyloid-β-Induced Neurotoxicity and Promotes Neurite Outgrowth in Rat Cultured Central Nervous System Neurons

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Journal of Pharmacology and Experimental Therapeutics

• Publication date

  2005-07-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1124/JPET.105.083543PMID 15798005
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Molecular Pathology of Alzheimer's Disease

  2013cited by this paper
• Nuclear factor-&kgr;B

  2005cited by this paper
• Nuclear factor-kappaB.

  2005cited by this paper
• β-Amyloid Peptides Induce Mitochondrial Dysfunction and Oxidative Stress in Astrocytes and Death of Neurons through Activation of NADPH Oxidase

  2004cited by this paper
• Aβ(25–35)-Induced Memory Impairment, Axonal Atrophy, and Synaptic Loss are Ameliorated by M1, A Metabolite of Protopanaxadiol-Type Saponins

  2004cited by this paper
• Impact of the selective estrogen receptor modulator, raloxifene, on neuronal survival and outgrowth following toxic insults associated with aging and Alzheimer's disease.

  2004cited by this paper
• Amyloid-β(25–35)-induced memory impairments correlate with cell loss in rat hippocampus

  2004cited by this paper
• Neurodegenerative diseases and oxidative stress

  2004cited by this paper
• Potential roles of insulin and IGF-1 in Alzheimer's disease.

  2003cited by this paper
• Neurotrophin secretory pathways and synaptic plasticity.

  2003cited by this paper
• Changes in Intracellular Calcium and Glutathione in Astrocytes as the Primary Mechanism of Amyloid Neurotoxicity

  2003cited by this paper
• Current Treatment for Alzheimer Disease and Future Prospects

  2003influential reference
• Regulation of axonal growth and guidance by the neurotrophin family of neurotrophic factors

  2003cited by this paper
• Microglia enhance beta-amyloid peptide-induced toxicity in cortical and mesencephalic neurons by producing reactive oxygen species.

  2002cited by this paper
• The state versus amyloid-β: the trial of the most wanted criminal in Alzheimer disease

  2002cited by this paper
• Microglia enhance β‐amyloid peptide‐induced toxicity in cortical and mesencephalic neurons by producing reactive oxygen species

  2002cited by this paper
• Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer's disease brain contribute to neuronal death.

  2002influential reference
• GABA is toxic for mouse striatal neurones through a transporter‐mediated process

  2002cited by this paper
• Determination of intracellular glutathione and thiols by high performance liquid chromatography with a gold electrode at the femtomole level: comparison with a spectroscopic assay.

  2002cited by this paper
• Signaling Events in Amyloid β-Peptide-induced Neuronal Death and Insulin-like Growth Factor I Protection*

  2002cited by this paper
• N‐Acetyl‐l‐cysteine protects SHSY5Y neuroblastoma cells from oxidative stress and cell cytotoxicity: effects on β‐amyloid secretion and tau phosphorylation

  2001cited by this paper
• Oxidative Damage Is the Earliest Event in Alzheimer Disease

  2001cited by this paper
• Pathogenesis of Neurodegenerative Disorders

  2001cited by this paper
• Cellular and Molecular Mechanisms Underlying Synaptic Degeneration and Neuronal Death in Alzheimer’s Disease

  2001influential reference
• Oxidative Alterations in Neurodegenerative Diseases

  2001influential reference
• Glutathione, oxidative stress and neurodegeneration.

  2000influential reference
• Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline.

  2000cited by this paper
• Selective glutamate receptor antagonists can induce or prevent axonal sprouting in rat hippocampal slice cultures.

  1999cited by this paper
• Insulin-like growth factor-1-mediated neuroprotection against oxidative stress is associated with activation of nuclear factor kappaB.

  1999cited by this paper
• Quantification of neuron survival in monolayer cultures using an enzyme-linked immunosorbent assay approach, rather than by cell counting.

  1999influential reference
• Characterization of LY231617 Protection Against Hydrogen Peroxide Toxicity

  1999cited by this paper
• Culturing Nerve Cell

  1999cited by this paper
• Insulin-like Growth Factor-1-mediated Neuroprotection against Oxidative Stress Is Associated with Activation of Nuclear Factor κB*

  1999cited by this paper
• Quantitative analysis of GAP-43 expression by neurons in microcultures using cell-ELISA.

  1997influential reference
• Lesion-induced axonal sprouting and hyperexcitability in the hippocampus in vitro: Implications for the genesis of posttraumatic epilepsy

  1997cited by this paper
• Insulin-like Growth Factor-I-mediated Neurite Outgrowth in Vitro Requires Mitogen-activated Protein Kinase Activation*

  1997cited by this paper
• Axons Regenerate with Correct Specificity in Horizontal Slice Culture of the Postnatal Rat Entorhino‐hippocampal System

  1994cited by this paper
• Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state

  1993cited by this paper
• Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species.

  1993cited by this paper
• Lesion-induced neurite sprouting and synapse formation in hippocampal organotypic cultures.

  1993cited by this paper
• The weaver gene encodes a nonautonomous signal for CNS neuronal differentiation.

  1992cited by this paper
• A simple method for organotypic cultures of nervous tissue

  1991cited by this paper
• A simple method for organotypic cultures of nervous tissue.

  1991cited by this paper
• Growth-associated protein, GAP-43, a polypeptide that is induced when neurons extend axons, is a component of growth cones and corresponds to pp46, a major polypeptide of a subcellular fraction enriched in growth cones.

  1986cited by this paper

• T817MA attenuates oxidative stress and ER stress via the HSP70–HSP90 pathway after brain ischemia in vitro and in vivo

  2025cites this paper
• T817MA protects against inflammation and pyroptosis in response to brain ischemia via activating Sirt1 signaling

  2025cites this paper
• "Current and emerging drug therapies in Alzheimer's disease: A pathophysiological Perspective".

  2024cites this paper
• Nuclear respiratory factor-1 (NRF1) induction drives mitochondrial biogenesis and attenuates amyloid beta-induced mitochondrial dysfunction and neurotoxicity

  2024cites this paper
• Targeted to neuronal organelles for CNS drug development.

  2023cites this paper
• Chaperone-Dependent Mechanisms as a Pharmacological Target for Neuroprotection

  2023cites this paper
• T817MA regulates mitochondrial dynamics via Sirt1 and Arc following subarachnoid hemorrhage.

  2023cites this paper
• Edonerpic maleate regulates glutamate receptors through CRMP2- and Arc-mediated mechanisms in response to brain trauma

  2022cites this paper
• A systematic review on drugs for synaptic plasticity in the treatment of dementia.

  2022cites this paper
• [CRMP2 binding compound accelerates functional recovery from central nervous system damage].

  2022cites this paper
• Recent Advances in the Development of Sigma Receptor Ligands as Cytotoxic Agents: A Medicinal Chemistry Perspective

  2021cites this paper
• Small Molecules Selectively Targeting Sigma-1 Receptor for the Treatment of Neurological Diseases.

  2020cites this paper
• Polysialylation and disease.

  2020cites this paper
• Safety and Efficacy of Edonerpic Maleate for Patients With Mild to Moderate Alzheimer Disease: A Phase 2 Randomized Clinical Trial.

  2019cites this paper
• Evaluation of edonerpic maleate as a CRMP2 inhibitor for pain relief

  2019cites this paper
• Pharmacological Enhancement of Stroke Rehabilitation.

  2019cites this paper
• Early Intervention and a Direction of Novel Therapeutics for the Improvement of Functional Outcomes in Schizophrenia: A Selective Review

  2018cites this paper
• CRMP2-binding compound, edonerpic maleate, accelerates motor function recovery from brain damage

  2018cites this paper
• Novel Drug Enhances Motor Recovery Following Brain Injury.

  2018cites this paper
• Relationships among Parvalbumin-Immunoreactive Neuron Density, Phase-Locked Gamma Oscillations, and Autistic/Schizophrenic Symptoms in PDGFR-β Knock-Out and Control Mice

  2015cites this paper
• 神経栄養因子様低分子化合物 T-817MA の統合失調症治療薬としての可能性

  2015cites this paper
• New Pharmacotherapy Targeting Cognitive Dysfunction of Schizophrenia via Modulation of GABA Neuronal Function

  2015cites this paper
• Effects of the neurotrophic agent T-817MA on oligomeric amyloid-β-induced deficits in long-term potentiation in the hippocampal CA1 subfield.

  2014cites this paper
• Cognitive Enhancers (Nootropics). Part 3: Drugs Interacting with Targets other than Receptors or Enzymes. Disease-modifying Drugs

  2013cites this paper
• T-817MA, but Not Haloperidol and Risperidone, Restores Parvalbumin-Positive γ-Aminobutyric Acid Neurons in the Prefrontal Cortex and Hippocampus of Rats Transiently Exposed to MK-801 at the Neonatal Period

  2012cites this paper
• T-817MA, a novel neurotrophic agent, ameliorates loss of GABAergic parvalbumin-positive neurons and sensorimotor gating deficits in rats transiently exposed to MK-801 in the neonatal period.

  2012cites this paper
• 3-Thiomethyl-5,6-(dimethoxyphenyl)-1,2,4-triazine improves neurite outgrowth and modulates MAPK phosphorylation and HSPs expression in H2O2-exposed PC12 cells.

  2012cites this paper
• Protective effect of neurotrophic agent T-817MA against inner ear barotrauma in the guinea pig.

  2011cites this paper
• Blocking Effects of Human Tau on Squid Giant Synapse Transmission and Its Prevention by T-817 MA

  2011cites this paper
• Structural diversity of neuritogenic substances and their application perspective.

  2011cites this paper
• The design and screening of drugs to prevent acquired sensorineural hearing loss

  2011cites this paper
• T-817MA, a neuroprotective agent, attenuates the motor and cognitive impairments associated with neuronal degeneration in P301L tau transgenic mice.

  2011cites this paper
• Improved Mitochondrial Function in Brain Aging and Alzheimer Disease – the New Mechanism of Action of the Old Metabolic Enhancer Piracetam

  2010cites this paper
• The metabolic enhancer piracetam ameliorates the impairment of mitochondrial function and neurite outgrowth induced by ß‐amyloid peptide

  2010cites this paper
• Mitochondrial Dysfunction: Common Final Pathway in Brain Aging and Alzheimer’s Disease—Therapeutic Aspects

  2010cites this paper
• Strategies for the Inhibition of Protein Aggregation in Human Diseases

  2010cites this paper
• Dysideamine, a new sesquiterpene aminoquinone, protects hippocampal neuronal cells against iodoacetic acid-induced cell death.

  2009cites this paper
• Oral Administration of Pharmacologically Active Substances to Squid: A Methodological Description

  2009cites this paper
• Structure‐based discovery of low molecular weight compounds that stimulate neurite outgrowth and substitute for nerve growth factor

  2009cites this paper
• T‐817MA, a neurotrophic agent, ameliorates the deficits in adult neurogenesis and spatial memory in rats infused i.c.v. with amyloid‐β peptide

  2009influential citation
• Drug development for Alzheimer's disease: where are we now and where are we headed?

  2009cites this paper
• Neuroprotective effects of T-817MA against noise-induced hearing loss.

  2008cites this paper
• Alterations in phospholipid and fatty acid lipid profiles in primary neocortical cells during oxidant-induced cell injury.

  2008cites this paper
• A neuroprotective agent, T-817MA (1-{3-[2-(1-benzothiophen-5-yl)ethoxy]propyl} azetidin-3-ol maleate), prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in mice.

  2008cites this paper
• T-817MA, a novel neurotrophic compound, ameliorates phencyclidine-induced disruption of sensorimotor gating

  2008influential citation
• An update on pharmacological approaches to neurodegenerative diseases

  2007cites this paper
• Ameliorative effects of a neuroprotective agent, T‐817MA, on place learning deficits induced by continuous infusion of amyloid‐β peptide (1–40) in rats

  2007cites this paper
• T-817MA, a novel neurotrophic agent, improves sodium nitroprusside-induced mitochondrial dysfunction in cortical neurons.

  2006cites this paper
• Toxicidade induzida pelos peptídeos AB42 e AB25-35 em modelo de cultura organotípica de hipocampo de ratos

  2006cites this paper
• Synaptic Neuroscience

  year unknowncites this paper
• Synaptic Neuroscience

  year unknowncites this paper